Friday 5-16-2014 Gilead Sciences (GILD) $GILD opened at

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Friday 5-16-2014 Gilead Sciences (GILD) $GILD opened at 80.30 hitting the high price of 80.84 and a day low of 79.22 with a total volume of 10,525,700. GILD had a previous close of 80.10 and has been seeing an average volume of 16,749,580.

Overall Average: 72% Buy

Recent stock forum discussions about GILD http://investorshangout.com/search?q=GILD&...mp;yt0=Go!

IBD 50's 5 Drug Giants Include Actavis, Gilead
at Investor's Business Daily - 2 hrs 4 mins ago
With the market wending its way through correction, now is the time to search for stocks primed to grow in the market's next leg up. Today's IBD 50 list of highly rated stocks is an excellent starting point. The computer-generated list ranks U.S.... (full story)

Can CVS Overcome the Drug Poised to "Break the Country?"
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Fri May 16, 5:30PM CDT
Consider the following quotes: "What they have done with this particular drug will break the country." "We expect the impact to be minimal for this year." These two quotes, the first from  Express Scripts '   chief medical officer Steven... (full story)

Final Glance: Biotechnology companies
AP - Fri May 16, 5:05PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading: (full story)

Data on Novo Nordisk's NovoEight - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 16, 4:30PM CDT
Novo Nordisk (NVO) recently announced positive interim data from its phase III trial, Guardian 2, on NovoEight at the World Federation of Haemophilia (WFH) World Congress. (full story)

Setback for Novartis' RLX030 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 16, 4:10PM CDT
Novartis (NVS) suffered a setback when the FDA issued a CRL to its Biologics License Application (BLA) for pipeline candidate RLX030 (serelaxin). (full story)

Update on Glaxo's Darapladib - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 16, 4:00PM CDT
GlaxoSmithKline's (GSK) darapladib performed disappointingly in a phase III study. (full story)

Midday Glance: Biotechnology companies
AP - Fri May 16, 12:33PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.: (full story)

XenoPort - Reckitt Benckiser Pharma Collaborate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 16, 10:50AM CDT
XenoPort, Inc. (XNPT) announced a deal with Reckitt Benckiser Pharmaceuticals for the development and commercialization of XenoPort's arbaclofen placarbil. (full story)

Early Glance: Biotechnology companies
AP - Fri May 16, 10:47AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.: (full story)

Rexahn Pharmaceuticals (RNN) Jumps: Stock Surges 19.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 16, 8:46AM CDT
Rexahn Pharmaceuticals (RNN) was a big mover last session, with shares rising over 19% on the day. (full story)

Drug-Pricing Rhetoric: Should Investors be Worried?
Brian Orelli, The Motley Fool - Motley Fool - Fri May 16, 8:30AM CDT
The drug-pricing story just won't go away. Bloomberg had a long article about the price of drugs claiming that there might be a drug that cost $1 million annually shortly. The pricing issue has previously been limited to orphan drug indications,... (full story)

Clovis Oncology, Inc. (CLVS) in Focus: Stock Surges 16 % - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 16, 7:44AM CDT
Clovis Oncology, Inc. (CLVS) was a big mover last session as the company saw its shares surge 16% on the day. (full story)

Pipeline Breakdown: Merck & Co. Inc.
Brian Orelli, The Motley Fool - Motley Fool - Thu May 15, 5:30PM CDT
Merck recently held its analyst day, updating analysts and investors listening in on its pipeline. While there weren't any major announcements -- no high-profile clinical trial results were announced -- there were a few tidbits that investors... (full story)

Incyte to Collaborate with AstraZeneca - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 15, 4:30PM CDT
Incyte Corporation (INCY) inked a deal with MedImmune, the global biologics research and development arm of AstraZeneca (AZN). (full story)

Celldex Gains on Bristol-Myers Squibb Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 15, 4:20PM CDT
Celldex Therapeutics, Inc. (CLDX) signed a deal with Bristol-Myers for the development of Celldex's varlilumab and Bristol-Myers' nivolumab in a phase I/II study. (full story)

Novartis Settles Gleevec Patent Litigation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 15, 10:40AM CDT
Novartis (NVS) has settled its litigation with the subsidiary of Sun Pharmaceutical Industries Ltd. in the U.S. (full story)

Progenics' Q1 Loss Narrows - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 15, 10:10AM CDT
Progenics Pharmaceuticals, Inc.'s (PGNX) loss narrows in the first quarter of 2014. (full story)

Gilead Sciences Inc. (GILD) Stock Research Links

GILD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Divorce Expertise: Obenhaus Adds CDFA Credential

Updated Category News Views 46

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Continue Reading
Motor Sensor Market to Exceed $5B by 2035 Surge

Updated Category News Views 3

Motor Sensor Market: Facing a New Era of Growth Buckle up, because this motor sensor market is gearing up for one heck of a ride. We're talking a clunky, gritty transition where the market's supposed to rev up to $5.47 billion by 2035, shooting from $3.21 billion in 2026. If you are crunching those numbers like a true market dog, that's a decent CAGR of 6.1%. But what's...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 0

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Gemmy's Orchestra of Lights Op. 2 Unveils New Show

Updated Category News Views 6

Jazzing Up the Holidays with Gemmy's Latest Innovation Just when you thought holiday displays couldn't get more extravagant, along comes Gemmy with its latest wonder—the Orchestra of Lights™ Op. 2. Exclusively hitting Lowe's shelves, this isn't your average set of twinkling bulbs. It's an all-out sensory assault, mixing tunes straight out of yuletide hit lists with...

Continue Reading
COhatch Preps for High-Stakes Ohio Pitch Contest

Updated Category News Views 31

Ohio Startups Gear Up for Another Fierce Faceoff You wouldn't find me betting against a hungry entrepreneur, especially with $25,000 on the line. That's the prize dangling at this year's Dublin Pitch Competition, hosted by COhatch and the City of Dublin. If there's one thing I'm certain of, it's that Ohio will see some real contenders stepping up on October 15....

Continue Reading
Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 186

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
WellBe Taps New Tech Chief to Elevate Home Care

Updated Category News Views 71

In a move that's got the healthcare world buzzing, WellBe Senior Medical just brought in a heavyweight to steer its digital ship. They've appointed Jeffrey Brown as their new Chief Digital & Information Officer. What's shaking? Brown's stepping into the ring to tackle the age-old healthcare dilemma: making tech work smarter, not harder, especially at home. From High-Tech...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 4

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading
Lowcountry Kids to Get Free Helmets at Safety Events

Updated Category News Views 5

Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...

Continue Reading
Reel Drops: Eightpoint's New Social Drama App Explored

Updated Category News Views 4

Mobile Drama: A Quick Escape with Reel Drops In this fast-moving world, where time feels as elusive as a daydream, Eightpoint is shaking up mobile entertainment with its brand-new app, Reel Drops. Based out of George Town, Cayman Islands, this app aims to give viewers a shot at swift, captivating storytelling without the marathon commitment of a binge-watch session. A New...

Continue Reading

Top 5 Most Recently Viewed Articles

Solstice Advanced Materials Financial Report Highlights

Updated Category News Views 327

Financial Overview of Solstice Advanced Materials Solstice Advanced Materials Inc. reported impressive financial results, showcasing net sales that reached $969 million, indicating a 7% increase year-over-year. This growth is significantly attributed to the rising demands across its Refrigerants, Electronic Materials, and Safety & Defense Solutions sectors. The growth in...

Continue Reading
Financial 15 Split Corp. Raises $92.2 Million in Offering

Updated Category News Views 151

Overview of Financial 15 Split Corp.'s Recent Offering Financial 15 Split Corp. has recently achieved a significant milestone by successfully completing an overnight offering of Preferred Shares, generating substantial gross proceeds totaling $92.2 million. This strategic move is set to enhance the company's investment portfolio significantly. Trading Details of Preferred...

Continue Reading
Highlights from Upcoming Major Earnings Announcements

Updated Category News Views 141

Upcoming Earnings Highlights Earnings season is buzzing as a wide variety of companies prepare to unveil their financial performance soon. Noteworthy players like Intuitive Surgical, Netflix (NASDAQ: NFLX), and Nestle are capturing the spotlight, along with several other significant corporations that are expected to deliver their results. Investors and analysts are keenly...

Continue Reading
Traders Anticipate Unprecedented Fed Meeting Outcomes This Year

Updated Category News Views 135

Uncertainty Surrounding Upcoming Federal Reserve Decisions Traders are bracing for the U.S. Federal Reserve's expected rate cut, leaving a thick veil of uncertainty hanging over global finance. As the meeting approaches, it is set to stir market volatility, creating a uniquely unpredictable environment. Market Predictions and Rate Cut Expectations Leading financial firms...

Continue Reading
AGCO Showcases Innovative Farming Solutions at Trade Shows

Updated Category News Views 383

Showcasing Innovation at the Upcoming Trade Shows AGCO Corporation (NYSE: AGCO), a global leader in agricultural machinery and precision technology, is set to elevate the agricultural experience at two major trade shows this February. The renowned brands Fendt and Massey Ferguson will spotlight their groundbreaking innovations designed with the farmer in mind. Exciting...

Continue Reading